http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013539778-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08
filingDate 2010-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2013-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2013539778-A
titleOfInvention Cancer treatment / inhibition of metastasis
abstract Disclosed are substances and methods for reducing or preventing metastatic behavior in VGSC-expressing cancers by eliminating at least the transient portion of the voltage-gated sodium channel current, with the effect of at least reducing the sustained portion of the current . Inhibition of metastatic cell behavior such as exfoliation, lateral motility, transverse migration and invasiveness using the known drugs ranolazine and riluzole has been demonstrated.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11634398-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016128490-A
priorityDate 2010-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005523314-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010033581-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010221246-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226458111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6603987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226495530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226495529

Total number of triples: 39.